Peptide record

TPDB05381

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05381
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb ToxinPred 3.0
standard
No
A 21-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLLSKVLGVGKKVLCGVSGLC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C90H164N24O24S2
ARNDEQHIMFPTWY
GL
2030.56
9.80
3
0
9
+3
-1.17
1.214
148.10
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
0.06
4
Residue Composition
number
0
A
0
R
0
N
0
D
2
C
0
E
0
Q
5
G
0
H
0
I
5
L
3
K
0
M
0
F
0
P
2
S
0
T
0
W
0
Y
4
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 5 H: 0 I: 0 L: 5 K: 3 M: 0 F: 0 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 4
Chemical Descriptors
21 reviewed residue count
C90H164N24O24S2 sequence-only estimate (linear, free termini)
2030.56 sequence-only estimate (linear, free termini)
9.80 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-1.17 sequence-only estimate (linear, free termini)
1.214 sequence-only estimate (linear, free termini)
Evidence Records 23 records
Evidence 1 Activity

Activity

MIC
Antibacterial
15 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram+ S. aureus (MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoni
Evidence 2 Activity

Activity

MIC
Antibacterial
2.5 µg/mL

Target

M. luteus

Source & Reference

dbAMP DRAMP

Other

Active against Gram+ S. aureus (MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aerug
Evidence 3 Activity

Activity

MIC
Antibacterial
5 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Active against Gram+ S. aureus (MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typh
Evidence 4 Activity

Activity

MIC
Antibacterial
10 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

dbAMP DRAMP

Other

(MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active agai
Evidence 5 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP

Other

5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active against C.albicans (MIC 150 ug/ml).
Evidence 6 Activity

Activity

MIC
Antibacterial
22 µg/mL

Target

S. typhimurium

Source & Reference

dbAMP DRAMP

Other

C 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active against C.albicans (MIC 150 ug/ml).
Evidence 7 Activity

Activity

MIC
Antibacterial
150 µg/mL

Target

C.albicans

Source & Reference

dbAMP DRAMP

Other

aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active against C.albicans (MIC 150 ug/ml).
Evidence 8 Activity

Activity

MIC
Antifungal
15 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram+ S. aureus (MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoni
Evidence 9 Activity

Activity

MIC
Antifungal
2.5 µg/mL

Target

M. luteus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against Gram+ S. aureus (MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aerug
Evidence 10 Activity

Activity

MIC
Antifungal
5 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against Gram+ S. aureus (MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typh
Evidence 11 Activity

Activity

MIC
Antifungal
10 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active agai
Evidence 12 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active against C.albicans (MIC 150 ug/ml).
Evidence 13 Activity

Activity

MIC
Antifungal
22 µg/mL

Target

S. typhimurium

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

C 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active against C.albicans (MIC 150 ug/ml).
Evidence 14 Activity

Activity

MIC
Antifungal
150 µg/mL

Target

C.albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active against C.albicans (MIC 150 ug/ml).
Evidence 15 Activity

Activity

MIC
Antiparasitic
15 µM

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram+ S. aureus (MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoni
Evidence 16 Activity

Activity

MIC
Antiparasitic
2.5 µg/mL

Target

M. luteus

Source & Reference

DRAMP

Other

Active against Gram+ S. aureus (MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aerug
Evidence 17 Activity

Activity

MIC
Antiparasitic
5 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Active against Gram+ S. aureus (MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typh
Evidence 18 Activity

Activity

MIC
Antiparasitic
10 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

DRAMP

Other

(MIC 15 uM), M. luteus (MIC 2.5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active agai
Evidence 19 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

DRAMP

Other

5 ug/ml), Gram-negative E. coli (MIC 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active against C.albicans (MIC 150 ug/ml).
Evidence 20 Activity

Activity

MIC
Antiparasitic
22 µg/mL

Target

S. typhimurium

Source & Reference

DRAMP

Other

C 5 uM), S. dysenteriae, K. pneumoniae (MIC 10 ug/ml), P. aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active against C.albicans (MIC 150 ug/ml).
Evidence 21 Activity

Activity

MIC
Antiparasitic
150 µg/mL

Target

C.albicans

Source & Reference

DRAMP

Other

aeruginosa (MIC 100 ug/ml), and S. typhimurium (MIC 22 ug/ml), and weakly active against C.albicans (MIC 150 ug/ml).
Evidence 22 Activity

Activity

1% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
1% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata. | FEBS Lett | 2001
Evidence 23 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref:11682065] It has 0.9% hemolytic activity at 100µg/ml against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
FEBS Lett. 2001 Oct 19 507(1):95-100.